-fibrate
Fibrates: drugs that activate PPAR-alpha to lower blood fats.
- Drugs ending in -fibrate: 9
- Approved somewhere: 5
- With a US drug page: 2
- Stem
- -fibrate
- Class
- Fibrates: drugs that activate PPAR-alpha to lower blood fats
- Sub-stems
- -brate
- Most common targets
- PPARA (4), Peroxisome proliferator-activated receptor (1)
Approved and clinical-stage drugs in ChEMBL whose names ending in -fibrate or one of its sub-stems, matched by spelling; those with a US drug page link to it.
| Acts on | |||
|---|---|---|---|
| Clofibrate | Approved | PPARA | Peroxisome proliferator-activated receptor alpha agonist |
| Fenofibrate | Approved | PPARA | Peroxisome proliferator-activated receptor alpha agonist |
| Bezafibrate | Approved | Peroxisome proliferator-activated receptor | Peroxisome proliferator-activated receptor agonist |
| Ciprofibrate | Approved | PPARA | Peroxisome proliferator-activated receptor alpha agonist |
| Pemafibrate | Approved | PPARA | Peroxisome proliferator-activated receptor alpha agonist |
| Etofibrate | Phase 2 | — | — |
| Ronifibrate | Phase 2 | — | — |
| Simfibrate | Phase 2 | — | — |
| Beclobrate | — | — | — |
Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO